Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study
- Y. Tanaka
- , T. Takeuchi
- , T. Mimori
- , K. Saito
- , M. Nawata
- , H. Kameda
- , T. Nojima
- , N. Miyasaka
- , T. Koike
研究成果: Article › 査読
246
リンクは新しいタブで開きます
被引用数
(Scopus)